1. Home
  2. REZI vs ABVX Comparison

REZI vs ABVX Comparison

Compare REZI & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REZI
  • ABVX
  • Stock Information
  • Founded
  • REZI 2018
  • ABVX 2013
  • Country
  • REZI United States
  • ABVX France
  • Employees
  • REZI N/A
  • ABVX 69
  • Industry
  • REZI Wholesale Distributors
  • ABVX
  • Sector
  • REZI Industrials
  • ABVX
  • Exchange
  • REZI Nasdaq
  • ABVX Nasdaq
  • Market Cap
  • REZI 6.1B
  • ABVX 6.7B
  • IPO Year
  • REZI N/A
  • ABVX N/A
  • Fundamental
  • Price
  • REZI $41.61
  • ABVX $86.72
  • Analyst Decision
  • REZI Buy
  • ABVX Strong Buy
  • Analyst Count
  • REZI 3
  • ABVX 9
  • Target Price
  • REZI $34.67
  • ABVX $94.11
  • AVG Volume (30 Days)
  • REZI 2.1M
  • ABVX 969.2K
  • Earning Date
  • REZI 11-06-2025
  • ABVX 08-11-2025
  • Dividend Yield
  • REZI N/A
  • ABVX N/A
  • EPS Growth
  • REZI N/A
  • ABVX N/A
  • EPS
  • REZI N/A
  • ABVX N/A
  • Revenue
  • REZI $7,399,000,000.00
  • ABVX $7,073,400.00
  • Revenue This Year
  • REZI $13.22
  • ABVX $4.44
  • Revenue Next Year
  • REZI $3.40
  • ABVX N/A
  • P/E Ratio
  • REZI N/A
  • ABVX N/A
  • Revenue Growth
  • REZI 20.00
  • ABVX N/A
  • 52 Week Low
  • REZI $14.18
  • ABVX $4.77
  • 52 Week High
  • REZI $43.96
  • ABVX $92.91
  • Technical
  • Relative Strength Index (RSI)
  • REZI 64.44
  • ABVX 68.69
  • Support Level
  • REZI $39.80
  • ABVX $81.90
  • Resistance Level
  • REZI $43.96
  • ABVX $90.70
  • Average True Range (ATR)
  • REZI 1.30
  • ABVX 2.75
  • MACD
  • REZI -0.31
  • ABVX -0.69
  • Stochastic Oscillator
  • REZI 45.98
  • ABVX 61.24

About REZI Resideo Technologies Inc.

Resideo Technologies Inc is a manufacturer and developer of technology-driven products and components that provide critical comfort, energy management, and safety and security solutions. The company has two reportable segments; Products and Solutions segment offers temperature and humidity control, energy products and solutions, water and air solutions, smoke and carbon monoxide detection home safety products, security panels, sensors, peripherals, wire and cable, communications devices, video cameras, other home-related lifestyle convenience solutions; and ADI Global Distribution segment includes wholesale distributor of low-voltage security products including access control, fire detection, security, and video products. It derives majority of its revenue from the United States.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: